These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7116694)

  • 1. Increased hydrazine excretion associated with systemic lupus erythematosus.
    Tanaka K; Jimi S; Kajiyama K; Nishigouri S; Kameda S; Yanase T; Yamaguchi M; Matsuyama K; Iguchi S
    Clin Immunol Immunopathol; 1982 Jan; 22(1):55-9. PubMed ID: 7116694
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetylator phenotype and metabolic disposition of isoniazid in Japanese patients with systemic lupus erythematosus.
    Ishizaki T; Horai Y; Koya G; Matsuyama K; Iguchi S
    Arthritis Rheum; 1981 Oct; 24(10):1245-54. PubMed ID: 7306226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.
    Horai Y; Ishizaki T; Sasaki T; Koya G; Matsuyama K; Iguchi S
    Br J Clin Pharmacol; 1982 Mar; 13(3):361-74. PubMed ID: 7059436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of hydrazine metabolites of isoniazid in human urine by gas chromatography.
    Timbrell JA; Wright JM; Smith CM
    J Chromatogr; 1977 Aug; 138(1):165-72. PubMed ID: 893592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydralazine urinary metabolites in systemic lupus erythematosus.
    Litwin A; Adams LE; Hess EV; McManus J; Zimmer H
    Arthritis Rheum; 1973; 16(2):217-20. PubMed ID: 4716433
    [No Abstract]   [Full Text] [Related]  

  • 6. Aromatic amines and the pathogenesis of lupus erythematosus.
    Reidenberg MM
    Am J Med; 1983 Dec; 75(6):1037-42. PubMed ID: 6196968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemical induction of systemic lupus erythematosus and lupus-like illnesses.
    Reidenberg MM
    Arthritis Rheum; 1981 Aug; 24(8):1004-9. PubMed ID: 6169347
    [No Abstract]   [Full Text] [Related]  

  • 8. Spontaneous systemic lupus erythematosus and acelylator phenotype.
    Larsson R; Karlsson E; Molin L
    Acta Med Scand; 1977; 201(3):223-6. PubMed ID: 848361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lupus erythematosus disseminatus and active isoniazid levels. A study of 47 cases].
    Godeau P; Aubert M; Imbert JC; Herreman G
    Ann Med Interne (Paris); 1973 Mar; 124(3):181-6. PubMed ID: 4716710
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiological studies of systemic lupus erythematosus in Japan].
    Ofuji S; Miyawaki S
    Ryumachi; 1975 Oct; 15(3):310-25. PubMed ID: 1209386
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetylation phenotypes and environmental chemical exposure of people with idiopathic systemic lupus erythematosus.
    Reidenberg MM; Drayer DE; Lorenzo B; Strom BL; West SL; Snyder ES; Freundlich B; Stolley PD
    Arthritis Rheum; 1993 Jul; 36(7):971-3. PubMed ID: 8318043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the metabolism of [14C]acetylhydrazine in rats.
    Wright JM; Timbrell JA
    Drug Metab Dispos; 1978; 6(5):561-6. PubMed ID: 30606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiological studies on systemic lupus erythematosus(SLE) (1)].
    Oara H; Oira M
    Nihon Eiseigaku Zasshi; 1975 Apr; 30(1):191. PubMed ID: 1169520
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs that induce systemic lupus erythematosus inhibit complement component C4.
    Sim E; Gill EW; Sim RB
    Lancet; 1984 Aug; 2(8400):422-4. PubMed ID: 6147500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of anti-inflammatory steroids on renal excretion of hydroxyproline in systemic lupus erythematosus].
    Cieślicka T
    Pol Arch Med Wewn; 1975 Aug; 54(2):101-7. PubMed ID: 1161533
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of antiphlogistic steroids on urinary hydroxyproline excretion in systemic lupus erythematosus.
    Cieślicka T
    Pol Med Sci Hist Bull (1973); 1976; 15(2):235-9. PubMed ID: 959050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrazine derivatives and induction of systemic lupus erythematosus.
    Pereyo N
    J Am Acad Dermatol; 1986 Mar; 14(3):514-5. PubMed ID: 3958266
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dynamics of excretion of glucocorticoids and their metabolites in patients with lupus erythematosus in the process of treatment].
    Lashmanova AP; Trofimova LI; Nikitina LV
    Vestn Dermatol Venerol; 1975 Jan; (1):25-9. PubMed ID: 1136578
    [No Abstract]   [Full Text] [Related]  

  • 19. The epidemiology of drug-induced systemic lupus erythematosus.
    Siegel M; Lee SL; Peress NS
    Arthritis Rheum; 1967 Oct; 10(5):407-15. PubMed ID: 6057644
    [No Abstract]   [Full Text] [Related]  

  • 20. Tubular dysfunction in systemic lupus erythematosus.
    Yeung CK; Wong KL; Ng RP; Ng WL
    Nephron; 1984; 36(2):84-8. PubMed ID: 6694783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.